Chat about Fusion Antibody accounts information. See how Fusion Antibody is performing financially.

Fusion Antibody Accounts Summary


Date of Accounts 20232022202120212020
StandardIFRSIFRSIFRSIFRSIFRS
      
 MillionsMillionsMillionsMillionsMillions
Income Statement30-03-202330-03-202231-03-202130-03-202131-03-2020
Revenue2.904.804.174.173.90
Operating Profit / Loss-2.86-1.32-1.25-1.25-1.06
Net Interestn/a-0.01-0.01-0.01-0.01
Pre Tax Profit-2.86-1.33-1.26-1.26-1.07
Post Tax Profit-2.60-1.20-2.90-2.90-0.70
Profit for the Period-2.60-1.20-2.90-2.90-0.70
Equity Holders of Parent Company-2.60-1.20n/a-2.90n/a
Minority Interestsn/an/an/an/an/a
      
Continuing EPS     
Earnings per Share (Basic)-10.00p-4.60p-11.40p-0.12p-3.20p
Earnings per Share (Diluted)-10.00p-4.50p-11.40p-0.12p-3.20p
Earnings per Share (Adjusted)-10.00p-4.60p-11.40p-0.12p-3.20p
Continuing and Discontinued EPS     
Earnings per Share (Basic)-10.00p-4.60p-11.40p-0.12p-3.20p
Earnings per Share (Diluted)-10.00p-4.50p-11.40p-0.12p-3.20p
Earnings per Share (Adjusted)-10.00p-4.60p-11.40p-0.12p-3.20p
      
Dividend per Sharen/apn/apn/apn/apn/ap
      
 MillionsMillionsMillionsMillionsMillions
Balance Sheet30-03-202330-03-202231-03-202130-03-202131-03-2020
Non-Current Assets     
Intangible Assetsn/an/an/an/an/a
Property, Plant and Equipment0.380.631.121.121.47
Investmentsn/an/an/an/an/a
Investment Propertiesn/an/an/an/an/a
Other Financial Assetsn/an/an/an/an/a
Other Non-Current Assetsn/an/an/an/a1.76
Total Non-Current Assets0.380.631.121.123.24
      
Current Assets     
Inventories0.540.580.480.480.34
Trade and Other Receivables0.951.651.441.540.89
Cash at Bank and in Hand0.202.052.692.691.54
Current Asset Investmentsn/an/an/an/an/a
Other Current Assetsn/an/a0.10n/a0.04
Total Current Assets1.694.284.714.712.80
      
Other Assetsn/an/an/an/an/a
Total Assets2.064.925.835.836.04
      
Current Liabilities     
Borrowings0.040.070.160.160.16
Other Current Liabilities0.841.140.830.830.83
Total Current Liabilities0.881.211.001.000.99
      
Net Current Assetsn/an/an/an/an/a
      
Non-Current Liabilities     
Borrowings0.040.000.070.070.22
Provisions0.020.020.020.020.02
Other Non-Current Liabilitiesn/an/an/an/an/a
Total Non-Current Liabilities0.060.020.090.090.24
      
Net Assets1.123.684.754.754.81
      
Capital and Reserves     
Share Capital1.041.041.021.020.88
Share Premium Account7.657.657.557.554.87
Other Reservesn/an/an/an/an/a
Retained Earnings-7.56-5.00-3.82-3.82-0.94
Shareholders Funds1.123.684.754.754.81
      
Minority Interests / Other Equityn/an/an/an/an/a
Total Equity1.123.684.754.754.81
      
 30-03-202330-03-202231-03-202130-03-202131-03-2020
Operating Margin-98.52%-27.61%-29.98%-29.99%-27.18%
Return on Capital Employed-234.65%-35.12%-25.03%-25.01%-20.35%
Dividend Covern/an/an/an/an/a
Dividend Yieldn/an/an/an/an/a
PE Ration/an/an/an/an/a
PEGn/an/an/an/an/a
Dividend per Share Growthn/a%n/a%n/a%n/a%n/a%
Net Asset Value per Share1.89p6.20p18.34p7.98p18.58p